Skip to content
Calculator
Guide

Looksmaxxing and peptides: what young men are being sold

Last updated: October 27, 2026 · 7 min read · By the Grey Peptides Editorial Board

Portrait of an attractive young man in a bathrobe, looking into the distance by a large window
Photo by Sergey Torbik on Pexels
Grey Peptides
Grey Peptides Editorial Board
Every status on this page carries the date it was checked. How we work
Key takeaways
  • A June 2026 Chainalysis report puts crypto payments to grey-market peptide vendors on a run rate above $100 million a year, fuelled first by political attention and later by looksmaxxing, and found Chinese chemical makers that had supplied fentanyl and amphetamine precursors selling peptides.
  • Most of what is marketed to looksmaxxers is unapproved, and graded medium on our evidence scale. No study shows any of it adds height, and the tanning and leanness products carry documented risks.
  • For parents: the grey market Chainalysis traced is paid in cryptocurrency, and several of the products are banned in tested sport. A doctor can assess worries about height, skin or weight.

What looksmaxxing is, and where peptides come in

'Looksmaxxing' is internet slang for maximising your looks, which Chainalysis describes as a viral internet subculture 1.

The money involved has grown fast. Chainalysis, a firm that analyses cryptocurrency transactions, reported in June 2026 that crypto payments to grey-market peptide vendors rose from about $12 million in the last quarter of 2025 to $32 million in the first quarter of 2026, a run rate of more than $100 million a year, fuelled first by sudden political legitimacy and later by the looksmaxxing subculture 1. Its report found that several Chinese chemical manufacturers that had supplied precursors for fentanyl and amphetamines had moved into peptide sales 1. A Fortune reporter described buying a peptide from a China-based seller over a messaging app, paying $109 in the stablecoin USDC 2.

The products discussed for looksmaxxing fall into a few groups: drugs to get lean, a tanning peptide, skin and hair peptides, and compounds that raise growth hormone, promoted for muscle or height. The table shows how each compares on our evidence grades, its US status and its status in sport 3:

CompoundSold forOur evidence gradeUS statusWADA 2026
SemaglutideGetting lean, 'face gains'HighFDA-approvedNot listed
RetatrutideGetting leanMediumIn trials, not approvedProhibited (by category)
Melanotan IITanningMediumResearch only, not approvedProhibited (by category)
GHK-CuSkin and hairMediumResearch only, not approvedProhibited (by category)
MK-677Height, muscle, 'bone density'MediumResearch only, not approvedProhibited
CJC-1295Muscle, heightMediumResearch only, not approvedProhibited
IpamorelinMuscle, heightMediumResearch only, not approvedProhibited
PT-141LibidoHighFDA-approvedNot listed

Two things stand out. Only the GLP-1 drugs and PT-141 are graded high, and their trials enrolled people with obesity or a sexual-desire disorder, not lean young men looking to change their appearance 4 3. And several of these products are banned in competitive sport 3.

Melanotan II: the tanning peptide

Melanotan II is a synthetic analogue of alpha-MSH, a hormone that darkens skin. It was tested in people in the 1990s: in a small pilot study, two of three healthy men developed darker skin, and side effects included spontaneous erections, mild nausea, yawning and sleepiness 5. It was never approved 3. A related compound, afamelanotide, is approved for a rare light-sensitivity disease, but that is a different molecule 3.

The melanotan II sold online is a research chemical. Vials bought from three online shops and labelled as 10 mg contained between 4.32 and 8.84 mg, and two shops' vials carried unknown impurities of 4% to 6% 6. Researchers who read 623 forum posts found people using it before sun holidays and fitness competitions, discussing sunbed use, and flagged pigmented skin lesions, infections, contaminated products and sunbed exposure as risks 7. Case reports link it to kidney damage: a renal infarction the authors attribute most likely to melanotan II, and earlier reports of muscle breakdown and kidney failure 8.

Height and growth hormone boosters

Height is the promise with the least behind it. Navepegritide, approved in 2026 to increase linear growth in achondroplasia, is approved only for children aged 2 and older whose growth plates (epiphyses) are still open 3. None of the products in the table has a study showing it adds height 3.

The products sold for height and muscle are growth hormone secretagogues, which push the body to release more growth hormone: MK-677, CJC-1295 and ipamorelin. MK-677 is not even a peptide but an oral small molecule 3. In older adults it raised growth hormone and IGF-1 substantially, but fasting glucose rose too 9; in obese men it increased lean mass without reducing fat, and glucose tolerance tests showed impairment at two and eight weeks 10. None of these compounds is approved, all three are prohibited in sport 3, and in healthy older adults even real growth hormone produced only small changes in body composition alongside more swelling, joint pain, carpal tunnel syndrome and breast enlargement 11. A study of bodybuilding forums found women using CJC-1295 for weight loss, muscle, younger-looking skin and sleep, alongside other performance and image drugs, and worrying about long-term consequences 12.

Getting lean: GLP-1 drugs

Semaglutide and tirzepatide work for weight loss, but the trials that showed it enrolled adults with obesity, or overweight with a weight-related condition: STEP 1, for example, required a body mass index of at least 30, or 27 with a related condition, and nausea and diarrhoea were its most common side effects 4. We found no trial testing them in lean young men.

Semaglutide bought online without a prescription may not be the approved product. When researchers bought semaglutide from online sellers without a prescription, semaglutide made up only 7.7% to 14.4% of the powder in each vial, against sellers' claims of at least 99% purity, a different measure, and endotoxin was measured at 8.95 EU/mg in one vial, and the other two were reported only as below 2.9 and 2.2 EU/mg 13. Retatrutide is not approved and is still investigational 3; our pipeline overview explains where it stands.

Skin and hair peptides

GHK-Cu, the copper peptide, is sold for skin and hair, including as an injection. Its evidence is mostly from cells and animals. The one small randomised trial we have on record, in 13 patients recovering from laser treatment, found no difference on blinded measures 14, and a 2025 review found a surprising absence of clinical studies of GHK-Cu 15. Our guide to injectable GHK-Cu covers the copper each vial carries and FDA's concerns about injected versions. Our skin and hair hub grades every topical peptide we cover.

The risks that apply to all of it

Some risks come with the market, not the molecule. Grey-market vials have tested under-strength and impure, as the melanotan II analysis above shows 6, and a seller's certificate of analysis does not prove what is in the vial; our guide to spotting a fake COA explains why. The melanotan II forum study flagged infection transmission and polypharmacy as hazards 7. In 2025 two women were left critically ill on ventilators after peptide injections at a longevity conference, and the cause was never determined, as our article on serious reactions describes.

Several products are banned in sport 3; our guide to peptide drug testing explains how athletes are caught, with and without a positive test.

What has actual evidence

For hair loss, our article on peptides for hair loss compares the peptide claims with the approved medicines. For skin, weight and muscle, a doctor or dermatologist can explain what has been tested in people.

What parents should know

The grey market Chainalysis traced is paid in cryptocurrency, and the reporter's purchase came from a China-based seller 1 2. Melanotan II, for example, is sold in vials as an injectable product 6. If a young person is interested in these products, the grades in our encyclopedia are a place to start a conversation, and a doctor can assess worries about height, skin, weight or mood.

Frequently asked questions

What peptides are used for looksmaxxing?

The products discussed include melanotan II for tanning, GHK-Cu for skin and hair, growth hormone boosters such as MK-677, CJC-1295 and ipamorelin for muscle or height, and GLP-1 drugs such as semaglutide for leanness. Only the GLP-1 drugs and PT-141 are graded high on our evidence scale, and their trials were not in lean young people.

Can peptides make you taller?

No study shows that any peptide sold online adds height. The approved growth treatment navepegritide is limited to children with achondroplasia whose growth plates are still open.

Is melanotan II safe?

It is not approved anywhere. Online vials have been found under-strength and impure, case reports link it to kidney damage, and dermatologists flag changes to pigmented skin lesions.

Is it legal to buy these peptides?

None of the products in the table except the approved GLP-1 drugs and PT-141 is an approved medicine in the US. Our legal status checker shows each compound's status by country.

Sources

  1. Chainalysis Team. The $100 million crypto 'looksmaxxing' boom: how Chinese cartel suppliers pivoted to the gray-market peptide ecosystem. Chainalysis blog, June 4, 2026 (modified June 5). Read October 3, 2026; findings re-checked October 27, 2026 against Decrypt's report of the study. Cited without a link.
  2. Weiss, B. I bought peptides with crypto. How my purchase helped fuel a $100 million gray-market, 'looksmaxxing' economy. Fortune, June 4, 2026. Read October 27, 2026.
  3. Grey Peptides encyclopedia: evidence grade, US status and 2026 WADA record for each compound; afamelanotide and retatrutide status; and the navepegritide approval (February 27, 2026; children 2 and older with achondroplasia and open epiphyses). Read October 27, 2026.
  4. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med, 384(11), 989-1002. PMID: 33567185
  5. Dorr, R. T., et al. (1996). Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sci, 58(20), 1777-84. PMID: 8637402
  6. Breindahl, T., et al. (2015). Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the Internet. Drug Test Anal, 7(2), 164-72. PMID: 24771717
  7. Gilhooley, E., et al. (2021). Melanotan II User Experience: A Qualitative Study of Online Discussion Forums. Dermatology, 237(6), 995-999. PMID: 34464955
  8. Peters, B., et al. (2020). Melanotan II: a possible cause of renal infarction: review of the literature and case report. CEN Case Rep, 9(2), 159-161. PMID: 31953620
  9. Chapman, I. M., et al. (1996). Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects. J Clin Endocrinol Metab, 81(12), 4249-57. PMID: 8954023
  10. Svensson, J., et al. (1998). Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. J Clin Endocrinol Metab, 83(2), 362-9. PMID: 9467542
  11. Liu, H., et al. (2007). Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med, 146(2), 104-15. PMID: 17227934
  12. Van Hout, M. C., et al. (2016). Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions. Subst Use Misuse, 51(1), 73-84. PMID: 26771670
  13. Ashraf, A. R., et al. (2024). Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study. J Med Internet Res, 26, e65440. PMID: 39509151
  14. Miller, T. R., et al. (2006). Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg, 8(4), 252-9. PMID: 16847171
  15. Mortazavi, S. M., et al. (2025). Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective. Bioimpacts, 15, 30071. PMID: 39963574

Educational information, not medical advice. Each dose in this guide names its source, an approved label or a published study. None is a recommendation for you. An unapproved compound has no established safe or effective human dose, and products sold for “research use only” are not made or tested for people. Talk to a doctor before acting on anything on this site, including before you start, stop or change any medicine or dose.

All articles

New guides and rule changes, by email

One short email when a peptide's legal status moves — an FDA or PCAC decision, a WADA list change, an enforcement action — plus new guides and tools. At most one a week, and none when nothing changes. The newsletter has not started sending yet: your first email will be its first issue.

We keep your email address and the page you signed up from, nothing else. How it works · Privacy · RSS instead